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journal homepage: www.jfma-onl ine.comLETTER TO THE EDITORPeculiarities of progressive external
ophthalmoplegia due to single mitochondrial
DNA deletionsDear Editor,
With interest we read the article by Hsiao et al1 about a 27-
year-old woman with chronic progressive external oph-
thalmoparesis (CPEO) but without ptosis due to a single
mitochondrial DNA (mtDNA) deletion of 4977 bp. We have
the following comments and concerns regarding this report.
Like mtDNA point mutations, mtDNA deletions occur in a
heteroplasmic fashion, that is, there is a mixture of deleted
and undeleted mtDNA within a cell or a mitochondrion.
What was the heteroplasmy rate of the deletion in the
presented patient? Did heteroplasmy rates vary between
different tissues? Were heteroplasmy rates highest in the
extraocular muscles?
Although most of the cases with CPEO occur sporadi-
cally, some familial cases have been reported.2 Familial
cases may follow an autosomal recessive, autosomal
dominant, or maternal trait of inheritance.2 Were first-
degree relatives of the index case investigated for the
mutation? Did any of the patient’s relatives present with
features of a mitochondrial disorder?
Although usually stable over years, CPEO may be pro-
gressive, resulting in affection of muscles other than the
extraocular ones and tissues other than the skeletal
muscle (CPEO-plus).3 Was the index case investigated for
phenotypic manifestations of the mtDNA deletion in
extraocular muscles or in nonskeletal muscle tissues?
Multisystem disease in CPEO may go along with cardio-
myopathy, conduction defects, arrhythmias, dysphagia,
pigmentary retinopathy, gastrointestinal dysfunction,
thyroid dysfunction, encephalopathy, cerebral calcifica-
tions, or polyneuropathy.4Conflicts of interest: The authors have no conflicts of interest
relevant to this article.
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BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/CPEO may not only be due to sporadic or hereditary
single mtDNA deletions but also due to mutations in nuclear
DNA-located genes, such as POLG1, POLG2, ANT1, DGUOK,
TK2, MPV17, PEO1 (twinkle), OPA1, or RRM2B, resulting in
multiple mtDNA deletions. How were multiple mtDNA de-
letions or mutations in one of the aforementioned genes
excluded?
Why were no biochemical investigations of the muscle
homogenate carried out? We should be informed about the
activity of the four complexes of the respiratory chain.
Were multiple or a single complex activity impaired? There
may be also aberrant adenosine triphosphate synthesis in
CPEO patients.
Overall, this interesting case stimulates a number of
concerns, which need to be addressed to further elucidate
open issues concerning diagnosis, familiarity, trans-
mission, phenotypic expression, and management of pa-
tients with CPEO due to a single mtDNA deletion. Because
there is a strong need to elucidate the genetic background
of mitochondrial disorders, it is important to take a
thorough family history and investigate relatives at risk for
CPEO.
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